SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Mar 5, 2014
Insider Transaction Report
Form 4
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-03-03+141,211→ 141,211 totalExercise: $6.15Exp: 2024-03-03→ Common Stock (141,211 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on March 3, 2015 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.